Kohji Takara

Kobe, 6508530, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Molecular signatures of triple-negative breast cancer cells acquiring palbociclib resistance via continuous exposure.

Molecular signatures of triple-negative breast cancer cells acquiring palbociclib resistance via continuous exposure.

Journal: Oncology letters
Published: February 13, 2026

Prolonged exposure to axitinib alters the molecular profile of Caki-2 renal cell carcinoma cells.

Prolonged exposure to axitinib alters the molecular profile of Caki-2 renal cell carcinoma cells.

Journal: Molecular and clinical oncology
Published: May 13, 2025

Involvement of everolimus‑induced ABCB1 downregulation in drug‑drug interactions.

Involvement of everolimus‑induced ABCB1 downregulation in drug‑drug interactions.

Journal: Biomedical reports
Published: June 05, 2024

Down-regulation of ABCB1 in Everolimus-resistant Renal Cell Carcinoma Cells.

Down-regulation of ABCB1 in Everolimus-resistant Renal Cell Carcinoma Cells.

Journal: Anticancer research
Published: April 12, 2024

Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus.

Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus.

Journal: Anticancer research
Published: July 11, 2023

Induction of Cross-resistance to ABCB1 Substrates in Venetoclax-resistant Human Leukemia HL60 Cells.

Induction of Cross-resistance to ABCB1 Substrates in Venetoclax-resistant Human Leukemia HL60 Cells.

Journal: Anticancer research
Published: July 07, 2021

Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents

Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: December 04, 2018

Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Annals of transplantation
Published: September 27, 2017

Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis.

Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis.

Journal: Oncology letters
Published: August 19, 2015

The interaction between oral melphalan and gastric antisecretory drugs: Impact on clinical efficacy and toxicity.

The interaction between oral melphalan and gastric antisecretory drugs: Impact on clinical efficacy and toxicity.

Journal: Molecular and clinical oncology
Published: July 15, 2015

Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.

Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.

Journal: The Journal of pharmacology and experimental therapeutics
Published: June 09, 2015

Quantitative interactome analysis reveals a chemoresistant edgotype.

Quantitative interactome analysis reveals a chemoresistant edgotype.

Journal: Nature communications
Published: December 31, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026